Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 375


Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.

Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, Wang M, Westerdaal NA, Kvalheim G, Gaudernack G.

PLoS One. 2013;8(3):e57020. doi: 10.1371/journal.pone.0057020. Epub 2013 Mar 4.


Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling.

Chen WJ, Ho CC, Chang YL, Chen HY, Lin CA, Ling TY, Yu SL, Yuan SS, Chen YJ, Lin CY, Pan SH, Chou HY, Chen YJ, Chang GC, Chu WC, Lee YM, Lee JY, Lee PJ, Li KC, Chen HW, Yang PC.

Nat Commun. 2014 Mar 25;5:3472. doi: 10.1038/ncomms4472.


Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.

Leung EL, Fiscus RR, Tung JW, Tin VP, Cheng LC, Sihoe AD, Fink LM, Ma Y, Wong MP.

PLoS One. 2010 Nov 19;5(11):e14062. doi: 10.1371/journal.pone.0014062.


Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.

Bahnassy AA, Fawzy M, El-Wakil M, Zekri AR, Abdel-Sayed A, Sheta M.

Transl Res. 2015 Mar;165(3):396-406. doi: 10.1016/j.trsl.2014.07.009. Epub 2014 Aug 7.


Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.

Geng S, Guo Y, Wang Q, Li L, Wang J.

Arch Dermatol Res. 2013 Jan;305(1):35-47. doi: 10.1007/s00403-012-1260-2. Epub 2012 Jun 28. Erratum in: Arch Dermatol Res. 2017 Jul;309(5):409.


CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.

Muraro MG, Mele V, Däster S, Han J, Heberer M, Cesare Spagnoli G, Iezzi G.

Stem Cells Transl Med. 2012 Aug;1(8):592-603. doi: 10.5966/sctm.2012-0003. Epub 2012 Aug 6.


Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.

Sung WJ, Park KS, Kwak SG, Hyun DS, Jang JS, Park KK.

Int J Clin Exp Pathol. 2015 Aug 1;8(8):8997-9009. eCollection 2015.


Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.

Roudi R, Madjd Z, Ebrahimi M, Najafi A, Korourian A, Shariftabrizi A, Samadikuchaksaraei A.

Tumour Biol. 2016 Sep;37(9):11843-11859. Epub 2016 Apr 5.


Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer.

Salcido CD, Larochelle A, Taylor BJ, Dunbar CE, Varticovski L.

Br J Cancer. 2010 May 25;102(11):1636-44. doi: 10.1038/sj.bjc.6605668. Epub 2010 Apr 27.


Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines.

Yan X, Luo H, Zhou X, Zhu B, Wang Y, Bian X.

Oncol Rep. 2013 Dec;30(6):2733-40. doi: 10.3892/or.2013.2784. Epub 2013 Oct 3.


Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.

Park E, Park SY, Sun PL, Jin Y, Kim JE, Jheon S, Kim K, Lee CT, Kim H, Chung JH.

Oncotarget. 2016 Jul 5;7(27):42502-42512. doi: 10.18632/oncotarget.9894.


Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.

Barr MP, Gray SG, Hoffmann AC, Hilger RA, Thomale J, O'Flaherty JD, Fennell DA, Richard D, O'Leary JJ, O'Byrne KJ.

PLoS One. 2013;8(1):e54193. doi: 10.1371/journal.pone.0054193. Epub 2013 Jan 17.


CD90 a potential cancer stem cell marker and a therapeutic target.

Shaikh MV, Kala M, Nivsarkar M.

Cancer Biomark. 2016;16(3):301-7. doi: 10.3233/CBM-160590. Review.


Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer.

Roudi R, Madjd Z, Korourian A, Mehrazma M, Molanae S, Sabet MN, Shariftabrizi A.

Cancer Biomark. 2014;14(6):457-67. doi: 10.3233/CBM-140424.


[Altered expressions of embryonic stem-related genes in pancreatic cancer stem cell].

Lu YH, Zhu H, Wang ZW, Fan XJ, Zhu SJ, Li XH, Wang Y, Lu JJ, Zhu MY.

Zhonghua Yi Xue Za Zhi. 2011 Nov 29;91(44):3107-10. Chinese.


Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.

Donnenberg VS, Donnenberg AD, Zimmerlin L, Landreneau RJ, Bhargava R, Wetzel RA, Basse P, Brufsky AM.

Cytometry B Clin Cytom. 2010 Sep;78(5):287-301. doi: 10.1002/cyto.b.20530. Epub 2010 Apr 30.


CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.

Seino S, Shigeishi H, Hashikata M, Higashikawa K, Tobiume K, Uetsuki R, Ishida Y, Sasaki K, Naruse T, Rahman MZ, Ono S, Simasue H, Ohta K, Sugiyama M, Takechi M.

J Oral Pathol Med. 2016 Mar;45(3):180-8. doi: 10.1111/jop.12348. Epub 2015 Sep 24.


Supplemental Content

Support Center